Amedisys Inc (AMED)
Payables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 1,596,573 | 1,392,562 | 1,366,627 | 1,203,440 | 1,064,696 | 1,241,260 | 1,251,859 | 1,270,615 | 1,260,425 | 1,260,426 | 1,248,493 | 1,240,973 | 1,233,356 | 1,222,924 | 1,210,298 | 1,196,835 | 1,185,369 | 1,174,236 | 1,165,276 | 1,160,800 |
| Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $1,596,573K ÷ $—K
= —
The payables turnover ratio for Amedisys Inc is not available for the period from March 31, 2020, to December 31, 2024, as the data is represented as "—". The payables turnover ratio is a financial metric that indicates how efficiently a company is able to pay off its suppliers or creditors.
Since the payables turnover ratio is not provided, it is challenging to assess Amedisys Inc's ability to manage its accounts payable effectively during this period. A higher payables turnover ratio typically suggests that a company is paying its suppliers more quickly, which can indicate strong liquidity and efficient working capital management. On the other hand, a lower payables turnover ratio may imply that the company is taking longer to pay its bills, potentially signaling cash flow issues or strained supplier relationships.
Without the specific data on payables turnover, it is not possible to analyze the trend or make a detailed assessment of Amedisys Inc's payables management over the specified period. It is essential for investors and stakeholders to monitor this ratio to evaluate the company's financial health and operational efficiency.
Peer comparison
Dec 31, 2024